TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds May 10, 1974
TCL Archive On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey. February 16, 2001
TCL Archive Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office. November 19, 2004
